Capitalize on the Increased Resolution of Experimental Structural Techniques & Evolving Predictive AI Model Accuracy to Determine 3D Structures of Pharmacologically Relevant Targets, Enabling Design of More Potent, Selective, & Tolerable Drug Candidates
Following the success of the Structure-Based Drug Design Summit in Boston, we’re delighted to be bringing this forum to West Coast to unite biopharma’s leaders driving the next era of rational drug design.Â
Advancements in experimental technologies are delivering atomic and even sub-Ã…ngstrom insights into complex protein structures, while predictive modelling, generative AI, and machine learning are redefining what’s possible in drug design. At the same time, with tightening R&D budgets the need to derisk early drug discovery programs through more rational drug design or more potent, selective and developable drug candidates is more important than ever. Â
This is your opportunity to join your peers from across Structural Biology, Medicinal Chemistry, Computational Chemistry, Protein Engineering, Machine Learning and more to stay at the forefront of innovation, benchmark your approaches, and discover how to translate structural insights into better therapies. Â
Attending Companies Include








